Table 1. CLDN18.2 expression in advanced gastric SRCC.
| Factors | Total cases (%) | Staining intensity ≥2+ in ≥40% of cells | Staining intensity ≥2+ in ≥90% of cells | |||
|---|---|---|---|---|---|---|
| N (%) | P value | N (%) | P value | |||
| All samples | 105 (100.0) | 68 (64.8) | – | 22 (21.0) | – | |
| Gender | ||||||
| Male | 71 (67.6) | 50 (70.4) | 0.079 | 17 (23.9) | 0.276 | |
| Female | 34 (32.4) | 18 (52.9) | 5 (14.7) | |||
| Age | ||||||
| ≥60 | 38 (36.2) | 22 (57.9) | 0.267 | 4 (10.5) | 0.042* | |
| <60 | 67 (63.8) | 46 (68.7) | 18 (26.9) | |||
| Stage | ||||||
| III | 92 (87.6) | 59 (64.1) | 0.719 | 19 (20.7) | 0.841 | |
| IV | 13 (12.4) | 9 (69.2) | 3 (23.1) | |||
*, represent for P<0.05. SRCC, signet-ring cell carcinoma.